Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with ...
Avicanna Inc.January 21, 2021 GMT
TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products has updated and amended its collaboration with Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, and initiated prioritized pre-clinical studies on the RHO Phyto formulations that are commercialized in Canada and Colombia. Additionally, the Company provides an update on research projects with the University of Toronto and Thompson Rivers University as well as a change to its management team.